Eurofins Launches Testing Solution for the Detection of SARS-CoV-2 on Surfaces

Eurofins Technologies, a provider of diagnostic technologies in the field of immunoassays and molecular detection methods, has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution that includes RNA extraction and tests kits based on real-time reverse-transcription polymerase chain-reaction (PCR) for the detection of SARS-CoV-2 in swabs of environmental surfaces.

Eurofins Technologies, a provider of diagnostic technologies in the field of immunoassays and molecular detection methods, has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution that includes RNA extraction and tests kits based on real-time reverse-transcription polymerase chain-reaction (PCR) for the detection of SARS-CoV-2 in swabs of environmental surfaces.

According to recently published studies, SARS-CoV-2 may remain viable on various surfaces for up to 72 hours. VIRSeek test kits and workflows provide fast tests to broadly screen for the presence of SARS-CoV-2, as well as verification of results with an independent test. This allows organizations in diverse industries, including healthcare and transportation, to determine, monitor, and eventually strengthen the effectiveness of sanitation measures.

Dr. Gilles Martin, the chief executive officer at Eurofins Scientific, said in a statement that the company is pleased to provide options to these industries for testing for the presence of SARS-CoV-2 in their environments. He noted that this solution can potentially play an important role in the documented effectiveness of sanitation and procedures and hygiene monitoring. “It is planned that this kit will also be used by hundreds of Eurofins testing laboratories around the world to offer fast turnaround testing services to support their clients’ needs wherever necessary,” he said.